1
|
Spontarelli K, Young VC, Sweazey R, Padro A, Lee J, Bueso T, Hernandez RM, Kim J, Katz A, Rossignol F, Turner C, Wilczewski CM, Maxwell GL, Holmgren M, Bailoo JD, Yano ST, Artigas P. ATP1A1-linked diseases require a malfunctioning protein product from one allele. Biochim Biophys Acta Mol Cell Res 2024; 1871:119572. [PMID: 37659504 DOI: 10.1016/j.bbamcr.2023.119572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Revised: 07/06/2023] [Accepted: 08/22/2023] [Indexed: 09/04/2023]
Abstract
Heterozygous germline variants in ATP1A1, the gene encoding the α1 subunit of the Na+/K+-ATPase (NKA), have been linked to diseases including primary hyperaldosteronism and the peripheral neuropathy Charcot-Marie-Tooth disease (CMT). ATP1A1 variants that cause CMT induce loss-of-function of NKA. This heterodimeric (αβ) enzyme hydrolyzes ATP to establish transmembrane electrochemical gradients of Na+ and K+ that are essential for electrical signaling and cell survival. Of the 4 catalytic subunit isoforms, α1 is ubiquitously expressed and is the predominant paralog in peripheral axons. Human population sequencing datasets indicate strong negative selection against both missense and protein-null ATP1A1 variants. To test whether haploinsufficiency generated by heterozygous protein-null alleles are sufficient to cause disease, we tested the neuromuscular characteristics of heterozygous Atp1a1+/- knockout mice and their wildtype littermates, while also evaluating if exercise increased CMT penetrance. We found that Atp1a1+/- mice were phenotypically normal up to 18 months of age. Consistent with the observations in mice, we report clinical phenotyping of a healthy adult human who lacks any clinical features of known ATP1A1-related diseases despite carrying a plasma-membrane protein-null early truncation variant, p.Y148*. Taken together, these results suggest that a malfunctioning gene product is required for disease induction by ATP1A1 variants and that if any pathology is associated with protein-null variants, they may display low penetrance or high age of onset.
Collapse
Affiliation(s)
- Kerri Spontarelli
- Department of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, TX, USA
| | - Victoria C Young
- Department of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, TX, USA
| | - Ryan Sweazey
- Department of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, TX, USA
| | - Alexandria Padro
- Department of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, TX, USA
| | - Jeannie Lee
- Department of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
| | - Tulio Bueso
- Department of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
| | - Roberto M Hernandez
- Department of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
| | - Jongyeol Kim
- Department of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
| | - Alexander Katz
- NIH Reverse Phenotyping Core, National Institutes of Health, Bethesda, MD, USA; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
| | - Francis Rossignol
- National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
| | - Clesson Turner
- NIH Reverse Phenotyping Core, National Institutes of Health, Bethesda, MD, USA; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
| | - Caralynn M Wilczewski
- NIH Reverse Phenotyping Core, National Institutes of Health, Bethesda, MD, USA; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
| | - George L Maxwell
- Women's Health Integrated Research Center, Inova Health System, Falls Church, VA, USA
| | - Miguel Holmgren
- Molecular Neurophysiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
| | - Jeremy D Bailoo
- Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
| | - Sho T Yano
- National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA; Molecular Neurophysiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA; Current address: Section of Pediatric Neurology, Department of Pediatrics, University of Chicago, Chicago, IL, USA.
| | - Pablo Artigas
- Department of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
| |
Collapse
|
2
|
Spontarelli K, Young VC, Sweazey R, Padro A, Lee J, Bueso T, Hernandez RM, Kim J, Katz A, Rossignol F, Turner C, Wilczewski CM, Maxwell GL, Holmgren M, Bailoo JD, Yano ST, Artigas P. ATP1A1 -linked diseases require a malfunctioning protein product from one allele. bioRxiv 2023:2023.03.05.531165. [PMID: 37090550 PMCID: PMC10120656 DOI: 10.1101/2023.03.05.531165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
Abstract
Heterozygous germline variants in ATP1A1 , the gene encoding the α1 subunit of the Na + /K + -ATPase (NKA), have been linked to diseases including primary hyperaldosteronism and the peripheral neuropathy Charcot-Marie-Tooth disease (CMT). ATP1A1 variants that cause CMT induce loss-of-function of NKA. This heterodimeric (αβ) enzyme hydrolyzes ATP to establish transmembrane electrochemical gradients of Na + and K + that are essential for electrical signaling and cell survival. Of the 4 catalytic subunit isoforms, α1 is ubiquitously expressed and is the predominant paralog in peripheral axons. Human population sequencing datasets indicate strong negative selection against both missense and protein-null ATP1A1 variants. To test whether haploinsufficiency generated by heterozygous protein-null alleles are sufficient to cause disease, we tested the neuromuscular characteristics of heterozygous Atp1a1 +/- knockout mice and their wildtype littermates, while also evaluating if exercise increased CMT penetrance. We found that Atp1a1 +/- mice were phenotypically normal up to 18 months of age. Consistent with the observations in mice, we report clinical phenotyping of a healthy adult human who lacks any clinical features of known ATP1A1 -related diseases despite carrying a protein-null early truncation variant, p.Y148*. Taken together, these results suggest that a malfunctioning gene product is required for disease induction by ATP1A1 variants and that if any pathology is associated with protein-null variants, they may display low penetrance or high age of onset.
Collapse
|
4
|
Acero JA, Simon A, Padro A, Santa Coloma O. Impact of local urban design and traffic restrictions on air quality in a medium-sized town. Environ Technol 2012; 33:2467-2477. [PMID: 23393990 DOI: 10.1080/09593330.2012.672472] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Traffic is the major air pollution source in most urban areas. Nowadays, most of the strategies carried out to improve urban air quality are focused on reducing traffic emissions. Nevertheless, acting locally on urban design can also reduce levels of air pollutants. In this paper, both strategies are studied in several scenarios for a medium-sized town of the Basque Country (Spain). Two main actions are analysed in order to reduce traffic emissions: (1) minor extension ofa pre-existing low emission zone (LEZ); (2) substitution of 10% of passenger cars that are older than 5 years by hybrid and electric vehicles. Regarding local urban design, three alternatives for the development of one side of a street canyon are considered: (1) a park with trees; (2) an open space without obstacles; (3) a building. Two different urban traffic dispersion models are used to calculate the air quality scenarios: PROKAS (Gaussian&box) to analyse the reduction of traffic emissions in the whole urban area and WinMISKAM (CFD) to evaluate specific urban designs. The results show the effectiveness of the analysed actions. On one hand, the definition of a small LEZ, as well as the introduction in 2015 of vehicles with new technology (hybrid and electric), results in minor impacts on PM10 and NO2 ambient concentrations. On the other hand, local urban design can cause significant variation in spatial distribution ofpollutant concentrations emitted inside street canyons. Consequently, urban planners should consider all these aspects when dealing with urban air pollution control.
Collapse
Affiliation(s)
- J A Acero
- TECNALIA Environmental Unit, Parque Tecnologico de Bizkaia, Edificio700, 48160 Derio, Bizkaia, Spain.
| | | | | | | |
Collapse
|